2017
DOI: 10.1172/jci95410
|View full text |Cite
|
Sign up to set email alerts
|

SHARPIN-mediated regulation of protein arginine methyltransferase 5 controls melanoma growth

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
48
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
6
2
1

Relationship

1
8

Authors

Journals

citations
Cited by 37 publications
(49 citation statements)
references
References 41 publications
(43 reference statements)
1
48
0
Order By: Relevance
“…The functional implications and regulatory mechanisms of SHARPIN need to be explored in detail in both on an immunological basis and therapeutic basis. SHARPIN has been highly explored in many disease conditions, especially in cancer stressing out its multiple roles in many LUBAC-independent regulatory mechanisms [28, 29], suggesting that this modification that we have identified, if not targeted for a proteosomal degradation, might be inhibiting only the LUBAC-dependent SHARPIN function, promoting its other cellular functions, which is out of scope for this study.…”
Section: Discussionmentioning
confidence: 99%
“…The functional implications and regulatory mechanisms of SHARPIN need to be explored in detail in both on an immunological basis and therapeutic basis. SHARPIN has been highly explored in many disease conditions, especially in cancer stressing out its multiple roles in many LUBAC-independent regulatory mechanisms [28, 29], suggesting that this modification that we have identified, if not targeted for a proteosomal degradation, might be inhibiting only the LUBAC-dependent SHARPIN function, promoting its other cellular functions, which is out of scope for this study.…”
Section: Discussionmentioning
confidence: 99%
“…The central role for integrin α11, uncovered here, in regulating mechanotransduction on collagen may also be essential to the pathological behavior of fibroblasts in cancerous or fibrotic tissues. As both SHARPIN and integrin α11β1 are significant regulators of cancer tumorigenesis and dissemination, as well as fibroblast contractility and collagen remodeling (He et al, 2010, Navab et al, 2016, Peuhu, Kaukonen et al, 2017, Tamiya et al, 2018, Zhu et al, 2007, increased understanding of their functional interplay is of wide interest. Finally, our finding that the mechanical output of fibroblasts can be strongly influenced by a single parameter of the molecular clutch, the integrin binding dynamics, highlights the tuneability of mechanotransduction, and its ability to trigger specific outputs in response to both internal and external parameters.…”
Section: Discussionmentioning
confidence: 99%
“…Our studies have identified SKI, a component of a transcriptional repressor complex antagonizing TGFβ signaling, as a substrate for PRMT5-MEP50-SHARPIN, which limits SKI recruitment to SOX10 and PAX3 promoters and derepresses them. In this context, PRMT5 control of SKI enhances melanoma growth by upregulating SOX10 and PAX3, which drive melanoma growth [53].…”
Section: Prmt5 Control Of Gene Expression By Non-histone Proteinsmentioning
confidence: 99%
“…LINC01138, a lncRNA encoded in a genomic region frequently amplified in HCC, binds to and stabilizes PRMT5 protein by interfering with CHIP binding and ubiquitination [114]. Binding of PRMT5 to SHARPIN, a component of the LUBAC complex, implies a possible crosstalk between PRMT5-mediated methylation and LUBAC-driven linear ubiquitination [40,53].…”
Section: Regulation By the Ups (Ubiquitin-proteasome System)mentioning
confidence: 99%